{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-22-000051","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2022-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.205681+00:00","generated_at":"2026-06-26T01:19:14.270257+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Penumbra Q1 2022: Revenue up 20.5% to $203.9M; operating loss of $4.0M vs income of $13.5M","bullets":["Revenue $203.9M, up 20.5% YoY (21.8% constant currency).","Vascular sales $122.8M (+37.7%); neuro $81.1M (+1.3%).","Gross margin 62.5% vs 65.8% Q1 2021, impacted by labor/logistics costs.","Operating loss $4.0M vs operating income $13.5M in Q1 2021.","SG&A expense $110.9M, up from $79.8M, driving swing to loss."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-22-000051","json":"https://secwatch.observer/filing/0001321732-22-000051.json","markdown":"https://secwatch.observer/filing/0001321732-22-000051.md","text":"https://secwatch.observer/filing/0001321732-22-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173222000051/0001321732-22-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173222000051/pen-20220503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T01:19:14.270257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}